Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Bioorganic Chemistry|September 5, 2021
Biological evaluation and synthesis of calcitroic acidOlivia B Yu, Daniel A Webb, Elliot S Di Milo, et al.
Nature Communications|July 4, 2019
Molecular tuning of farnesoid X receptor partial agonismDaniel Merk, Sridhar Sreeramulu, Denis Kudlinzki, et al.
Journal of Medicinal Chemistry|August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic SteatohepatitisJurema Schmidt, Marco Rotter, Tim Weiser, et al.
Journal of Medicinal Chemistry|June 8, 2018
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed PolypharmacologySimone Schierle, Cathrin Flauaus, Pascal Heitel, et al.
Journal of Medicinal Chemistry|July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Romy Busch, Felix Nawa, et al.
Journal of Medicinal Chemistry|April 9, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding ModeThomas Hanke, Sun-Yee Cheung, Whitney Kilu, et al.
Frontiers in Pharmacology|April 6, 2019
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γTamara Göbel, Olaf Diehl, Jan Heering, et al.
Journal of Medicinal Chemistry|July 28, 2017
Nonacidic Farnesoid X Receptor ModulatorsDaniel Flesch, Sun-Yee Cheung, Jurema Schmidt, et al.
Nature Communications|January 17, 2025
Author Correction: Prospective de novo drug design with deep interactome learningKenneth Atz, Leandro Cotos, Clemens Isert, et al.
Nature Communications|April 22, 2024
Prospective de novo drug design with deep interactome learningKenneth Atz, Leandro Cotos, Clemens Isert, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Bioorganic Chemistry|September 5, 2021
Biological evaluation and synthesis of calcitroic acidOlivia B Yu, Daniel A Webb, Elliot S Di Milo, et al.
Nature Communications|July 4, 2019
Molecular tuning of farnesoid X receptor partial agonismDaniel Merk, Sridhar Sreeramulu, Denis Kudlinzki, et al.
Journal of Medicinal Chemistry|August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic SteatohepatitisJurema Schmidt, Marco Rotter, Tim Weiser, et al.
Journal of Medicinal Chemistry|June 8, 2018
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed PolypharmacologySimone Schierle, Cathrin Flauaus, Pascal Heitel, et al.
Journal of Medicinal Chemistry|July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Romy Busch, Felix Nawa, et al.
Journal of Medicinal Chemistry|April 9, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding ModeThomas Hanke, Sun-Yee Cheung, Whitney Kilu, et al.
Frontiers in Pharmacology|April 6, 2019
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γTamara Göbel, Olaf Diehl, Jan Heering, et al.
Journal of Medicinal Chemistry|July 28, 2017
Nonacidic Farnesoid X Receptor ModulatorsDaniel Flesch, Sun-Yee Cheung, Jurema Schmidt, et al.
Nature Communications|January 17, 2025
Author Correction: Prospective de novo drug design with deep interactome learningKenneth Atz, Leandro Cotos, Clemens Isert, et al.
Nature Communications|April 22, 2024
Prospective de novo drug design with deep interactome learningKenneth Atz, Leandro Cotos, Clemens Isert, et al.
Pageof 17